Antler, Adriane M. Ph.D.

Current Employment Position(s)

Partner

Lawyer Overview

Adriane Antler has extensive experience in obtaining and evaluating intellectual property protection and in providing strategic counsel to clients. Her practice involves the areas of biotechnology, bioinformatics, and pharmaceuticals.

In addition to the preparation and prosecution of patent applications, a substantial part of Adriane's practice is devoted to the preparation of patentability, infringement, and validity opinions. She performs due diligence evaluations of patent portfolios and provides advice on validity and freedom-to-operate issues in connection with potential investments, licenses, and acquisitions. She has in-depth experience with ex parte and inter partes reexaminations. Adriane also participates extensively in opposition proceedings before the European Patent Office and has participated in patent litigations. She has negotiated and prepared contracts involving intellectual property issues such as license, consulting, and sponsored research agreements.

Representative clients include Antigenics, ConjuChem Biotechnologies, Essex Woodlands Health Ventures, Exelixis, Pathwork Diagnostics, and Yale University.

Since November 2007, Adriane has served as a non-trustee member of the Technology Transfer Committee of the Board of Trustees of The Rockefeller University. She is a member of the American Bar Association, the New York State Bar Association, the New York Intellectual Property Law Association, and the New York Academy of Sciences.

Areas of Practice

• Intellectual Property
• Patent Litigation
• Patent Prosecution
• Biotechnology
• Life Sciences

Representative Cases

• ALPS South Corp. defends against patent infringement action involving sleeves and liners for prosthetic devices
• Antigenics develops patent portfolio for cancer and infectious disease therapies
• Attenuon builds patent portfolio for cancer therapeutics
• Baker Brothers Investments conducts patent due diligence investigations
• ConjuChem develops patent portfolio and participates in inter partes reexamination proceeding relating to therapeutic peptide conjugates
• Danske Bank completes €103.5 million rights offering by NeuroSearch A/S , (2009)
• Danske Markets and Handelsbanken Capital Markets act as placement agent in €57.6 million rights offering by NeuroSearch A/S , (2009)
• EluSys develops patent portfolio for antibody heteropolymers for treatment of cancer and infectious disease
• Essex Woodlands Health Ventures conducts patent due diligence investigations
• Exelixis builds patent portfolio relating to the Notch signal transduction pathway
• H. Lee Moffitt Cancer Center and Research Institute builds patent portfolio for cancer therapy and diagnostics
• NanoString develops patent portfolio for analyte detection probes
• P.N. Gerolymatos develops patent portfolio for cancer treatment
• P.N. Gerolymatos prosecutes and litigates patents relating to neurodegenerative disorders
• Pathwork Diagnostics establishes patent portfolio for cancer diagnostics and bioinformatics
• PharmaStem builds patent portfolio for umbilical cord blood stem cells and their therapeutic use
• Renovis establishes patent portfolio for therapeutics for pain and neurological injury and disease
• Rosetta Inpharmatics establishes patent portfolio for expression profiling, genomics, and bioinformatics
• Seattle Genetics builds patent portfolio for antibodies and antibody-drug conjugates for cancer treatment
• Yale University develops patent portfolio for vaccines

West Practice Categories

Copyrights, Intellectual Property Law, International Intellectual Property, Patent Litigation, Patents, Technology Licensing, Trade Dress, Trade Secrets, Trademarks

Bar Admissions

• District of Columbia
• New Jersey
• New York

Education

• Fordham University
• Rockefeller University (The)
• Yale University

Published Works

• The Patenting of Living Organisms and Natural products, coauthor, Encyclopedia of Microbiology, Volume 3, Second Editiion, Academic Press, 2000
• Book Review: Patent Law in Principle and in Practice, Bio/Technology 11:742, 1993
• The Utilization of United States Patents to Prevent the Importation and Sale of Gray Goods, coauthor, The Trademark Reporter 83:481-494, 1993
• I. Characterization of a Drosophila melanogaster gene homologous to the erbB oncogene and the epidermal growth factor receptor gene. II. Phosphorylation of tyrosine in vinculin upon transformation by various avian sarcoma viruses, Ph.D. Thesis, 1986
• Increased phosphorylation of tyrosine in vinculin does not occur upon transformation by some avian sarcoma viruses, Mol. Cell. Biol. 5:263-267, 1985
• Cloning and characterization of a Drosophila melanogaster gene homologous to the erbB oncogene, Abstract, Cold Spring Harbor RNA Tumor Virus Meeting, Cold Spring Harbor, New York, 1985
• Transformation by avian sarcoma viruses and the distribution of vinculin and actin in transformed cells: the role of vinculin tyrosine phosphorylation, Abstract, Cold Spring Harbor RNA Tumor Virus Meeting, Cold Spring Harbor, New York, 1983
• Glycogen debrancher deficiency is reproduced in muscle culture, Ann. Neurol. 98:283-288, 1981

Address

222 East 41st Street
New York, NY 10017-6702

Phones

1.212.326.3630 (Business Phone)

Faxes

1.212.755.7306 (Business Fax)

Emails

Contact Us (Business Email)

Websites

http://www.jonesday.com